{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:13:19Z","timestamp":1698970399247},"reference-count":15,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,6,8]],"date-time":"2009-06-08T00:00:00Z","timestamp":1244419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Monitoring and repeated staging is of substantial importance in many patients with primary cutaneous T\u2010cell lymphomas (CTCL). For primary cutaneous B\u2010cell lymphomas (CBCL), extensive initial staging is the mainstay for correct diagnosis.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To evaluate the value of somatostatin receptor scintigraphy using the radiolabeled somatostatin analog <jats:sup>111<\/jats:sup>In\u2010pentetreotide in comparison to conventional imaging methods for the staging of patients with primary CTCL and primary CBCL.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Twenty\u2010two patients (15 patients with histologically verified CTCL and 7 patients with histologically verified CBCL) were included. Stage of disease was established by physical examination, laboratory screening, skin inspection, palpation of superficial lymph nodes, sonography and computed tomography (CT) in patients with advanced clinical stage. Focally elevated tracer uptake of <jats:sup>111<\/jats:sup>In\u2010pentetreotide was compared to common imaging modalities, physical aspect and digital photographs of the respective skin lesions.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Of the 15 patients with CTCL, only 4 (27%) showed positive scintigraphic results, but not in all sites of lymphomatous involvement. None of the five patients with mycosis fungoides in stage I, nor any of the four patients with S\u00e9zary syndrome, had a positive <jats:sup>111<\/jats:sup>In\u2010 pentetreotide scan. Of the seven patients with CBCL three positive scintigraphic results (43%) could be obtained: in two patients with a follicular center lymphoma and one patient with a diffuse large B\u2010cell lymphoma \u2013 leg type, but again not in all apparent sites of lymphoma.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Based on our results, we do not recommend the use of somatostatin receptor scintigraphy for routine staging of patients with CTCL and CBCL. As our series includes only 22 patients, and the number of patients with rarer variants of CTCL was rather small, it might be too premature to abandon SST\u2010R in the staging of patients with cutaneous lymphomas.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2009.03330.x","type":"journal-article","created":{"date-parts":[[2009,6,9]],"date-time":"2009-06-09T02:43:22Z","timestamp":1244515402000},"page":"13-17","source":"Crossref","is-referenced-by-count":4,"title":["Somatostatin receptor scintigraphy in primary cutaneous T\u2010 and B\u2010cell lymphomas"],"prefix":"10.1111","volume":"24","author":[{"given":"J","family":"Valencak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Trautinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Raderer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Chott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Der\u2010Petrossian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Ivancic\u2010Brandenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Knobler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Kurtaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,12,7]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3502"},{"key":"e_1_2_5_3_2","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze R","year":"1997","journal-title":"Blood"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.4.504"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.7.857"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1200\/JCO.2001.19.3.779","article-title":"Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides","volume":"19","author":"De Conick E","year":"2001","journal-title":"J Clin Oncol"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.4.1150"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910501)67:9<2311::AID-CNCR2820670918>3.0.CO;2-0"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.126.7.914"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.5.577"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.2070"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90276-5"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb07864.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.01.025"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01577.x"},{"key":"e_1_2_5_16_2","first-page":"15","article-title":"Neuropeptides and their receptors in the immune system","volume":"31","author":"Van Hagen PM","year":"1999","journal-title":"Ann Med"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2009.03330.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2009.03330.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T12:50:53Z","timestamp":1698929453000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2009.03330.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,7]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1111\/j.1468-3083.2009.03330.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03330.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,7]]}}}